Large owner Insight Holdings Group, Llc converted options into 530,982 shares and sold $38,137,011 worth of shares (530,982 units at $71.82) (SEC Form 4)

6/29/26 9:25:38 PM ET

$HNGE

EDP Services

Technology

Get the next $HNGE alert in real time by email

SEC FORM 4SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Insight Holdings Group, LLC

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS

1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	06/25/2026		C		265,169	A	⁽⁸⁾	265,169	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/25/2026		C		6,309	A	⁽⁸⁾	6,309	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/25/2026		C		217,442	A	⁽⁸⁾	217,442	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/25/2026		C		42,062	A	⁽⁸⁾	42,062	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/25/2026		S⁽¹²⁾		220,302	D	$71.5879⁽⁹⁾	44,867	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/25/2026		S⁽¹²⁾		5,242	D	$71.5879⁽⁹⁾	1,067	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/25/2026		S⁽¹²⁾		180,651	D	$71.5879⁽⁹⁾	36,791	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/25/2026		S⁽¹²⁾		34,945	D	$71.5879⁽⁹⁾	7,117	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/25/2026		S⁽¹²⁾		27,879	D	$72.8509⁽¹⁰⁾	16,988	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/25/2026		S⁽¹²⁾		664	D	$72.8509⁽¹⁰⁾	403	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/25/2026		S⁽¹²⁾		22,861	D	$72.8509⁽¹⁰⁾	13,930	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/25/2026		S⁽¹²⁾		4,422	D	$72.8509⁽¹⁰⁾	2,695	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/25/2026		S⁽¹²⁾		16,988	D	$73.1935⁽¹¹⁾	0	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/25/2026		S⁽¹²⁾		403	D	$73.1935⁽¹¹⁾	0	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/25/2026		S⁽¹²⁾		13,930	D	$73.1935⁽¹¹⁾	0	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/25/2026		S⁽¹²⁾		2,695	D	$73.1935⁽¹¹⁾	0	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Class B Common Stock	⁽⁸⁾	06/25/2026		C			265,169	⁽⁸⁾	⁽⁸⁾	Class A Common Stock	265,169	⁽⁵⁾	3,949,452	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class B Common Stock	⁽⁸⁾	06/25/2026		C			6,309	⁽⁸⁾	⁽⁸⁾	Class A Common Stock	6,309	⁽⁵⁾	93,972	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class B Common Stock	⁽⁸⁾	06/25/2026		C			217,442	⁽⁸⁾	⁽⁸⁾	Class A Common Stock	217,442	⁽⁵⁾	3,238,598	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class B Common Stock	⁽⁸⁾	06/25/2026		C			42,062	⁽⁸⁾	⁽⁸⁾	Class A Common Stock	42,062	⁽⁵⁾	626,475	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾

1. Name and Address of Reporting Person^*

Insight Holdings Group, LLC

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS

1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Insight Venture Associates X, L.P.

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS

1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Insight Venture Associates X, Ltd.

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS

1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Insight Venture Partners X, L.P.

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS

1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Insight Venture Partners (Cayman) X, L.P.

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS

1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Insight Venture Partners (Delaware) X, L.P.

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS

1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Insight Venture Partners X (Co-Investors), L.P.

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS

1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

Explanation of Responses:

1. See Exhibit 99.1

2. See Exhibit 99.1

3. See Exhibit 99.1

4. See Exhibit 99.1

5. See Exhibit 99.1

6. See Exhibit 99.1

7. See Exhibit 99.1

8. See Exhibit 99.1

9. See Exhibit 99.1

10. See Exhibit 99.1

11. See Exhibit 99.1

12. See Exhibit 99.1

Remarks:

This Form 4 is the first of two Form 4s filed relating to the same event. The Form 4 has been split into two filings because there are more than 30 rows in Table I, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 30 rows in Table I. Each Form 4 is filed by Designated Filer, Insight Holdings Group, LLC.

	Insight Venture Partners X, L.P., By: Insight Venture Associates X, L.P., its general partner, By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer	06/29/2026
	Insight Venture Partners (Cayman) X, L.P., By: Insight Venture Associates X, L.P., its general partner, By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer	06/29/2026
	Insight Venture Partners (Delaware) X, L.P., By: Insight Venture Associates X, L.P., its general partner, By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer	06/29/2026
	Insight Venture Partners X (Co-Investors), L.P., By: Insight Venture Associates X, L.P., its general partner, By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer	06/29/2026
	Insight Holdings Group, LLC, By: /s/ Andrew Prodromos/Attorney-in-Fact	06/29/2026
	Insight Venture Associates X Ltd., By: /s/ Andrew Prodromos/Authorized Officer	06/29/2026
	Insight Venture Associates X, L.P., By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Get the next $HNGE alert in real time by email

Recent Analyst Ratings for

$HNGE

Date	Price Target	Rating	Analyst
1/9/2026	$68.00	Overweight	Wells Fargo
9/5/2025	$56.00	Neutral	Robert W. Baird
7/14/2025	$58.00	Mkt Outperform	Citizens JMP
6/16/2025		Outperform	William Blair
6/16/2025	$48.00	Buy	Truist
6/16/2025	$48.00	Buy	Stifel
6/16/2025	$45.00	Outperform	Raymond James
6/16/2025	$41.00	Overweight	Piper Sandler

More analyst ratings

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security (Instr. 3)

2. Transaction Date (Month/Day/Year)

2A. Deemed Execution Date, if any (Month/Day/Year)

3. Transaction Code (Instr. 8)

4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)

5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)

6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)

7. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

Amount

(A) or (D)

Price

Class A Common Stock

06/25/2026

265,169

⁽⁸⁾

265,169

See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾

Class A Common Stock

06/25/2026

6,309

⁽⁸⁾

6,309

See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾

Class A Common Stock

06/25/2026

217,442

⁽⁸⁾

217,442

See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾

Class A Common Stock

06/25/2026

42,062

⁽⁸⁾

42,062

See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾

Class A Common Stock

06/25/2026

S⁽¹²⁾

220,302

$71.5879⁽⁹⁾

44,867

See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾

Class A Common Stock

06/25/2026

S⁽¹²⁾

5,242

$71.5879⁽⁹⁾

1,067

See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾

Class A Common Stock

06/25/2026

S⁽¹²⁾

180,651

$71.5879⁽⁹⁾

36,791

See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾

Class A Common Stock

06/25/2026

S⁽¹²⁾

34,945

$71.5879⁽⁹⁾

7,117

See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾

Class A Common Stock

06/25/2026

S⁽¹²⁾

27,879

$72.8509⁽¹⁰⁾

16,988

See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾

Class A Common Stock

06/25/2026

S⁽¹²⁾

664

$72.8509⁽¹⁰⁾

403

See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾

Class A Common Stock

06/25/2026

S⁽¹²⁾

22,861

$72.8509⁽¹⁰⁾

13,930

See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾

Class A Common Stock

06/25/2026

S⁽¹²⁾

4,422

$72.8509⁽¹⁰⁾

2,695

See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾

Class A Common Stock

06/25/2026

S⁽¹²⁾

16,988

$73.1935⁽¹¹⁾

See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾

Class A Common Stock

06/25/2026

S⁽¹²⁾

403

$73.1935⁽¹¹⁾

See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾

Class A Common Stock

06/25/2026

S⁽¹²⁾

13,930

$73.1935⁽¹¹⁾

See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾

Class A Common Stock

06/25/2026

S⁽¹²⁾

2,695

$73.1935⁽¹¹⁾

See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Class B Common Stock

⁽⁸⁾

06/25/2026

265,169

⁽⁸⁾

Class A Common Stock

265,169

⁽⁵⁾

3,949,452

See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾

Class B Common Stock

⁽⁸⁾

06/25/2026

6,309

⁽⁸⁾

Class A Common Stock

6,309

⁽⁵⁾

93,972

See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾

Class B Common Stock

⁽⁸⁾

06/25/2026

217,442

⁽⁸⁾

Class A Common Stock

217,442

⁽⁵⁾

3,238,598

See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾

Class B Common Stock

⁽⁸⁾

06/25/2026

42,062

⁽⁸⁾

Class A Common Stock

42,062

⁽⁵⁾

626,475

See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾

Recent Analyst Ratings for

$HNGE

Date	Price Target	Rating	Analyst
1/9/2026	$68.00	Overweight	Wells Fargo
9/5/2025	$56.00	Neutral	Robert W. Baird
7/14/2025	$58.00	Mkt Outperform	Citizens JMP
6/16/2025		Outperform	William Blair
6/16/2025	$48.00	Buy	Truist
6/16/2025	$48.00	Buy	Stifel
6/16/2025	$45.00	Outperform	Raymond James
6/16/2025	$41.00	Overweight	Piper Sandler

More analyst ratings

Large owner Insight Holdings Group, Llc converted options into 530,982 shares and sold $38,137,011 worth of shares (530,982 units at $71.82) (SEC Form 4)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$HNGE

Large owner Insight Holdings Group, Llc converted options into 530,982 shares and sold $38,137,011 worth of shares (530,982 units at $71.82) (SEC Form 4)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$HNGE

$HNGE
Insider Trading

Large owner Insight Holdings Group, Llc converted options into 426,171 shares and sold $38,446,957 worth of shares (426,171 units at $90.21) (SEC Form 4)

Director Sloat Tyler was granted 246 shares, increasing direct ownership by 2% to 10,210 units (SEC Form 4)

Chief Financial Officer Budge James covered exercise/tax liability with 4,614 shares, decreasing direct ownership by 1% to 430,786 units (SEC Form 4) to satisfy tax liability

$HNGE
SEC Filings

SEC Form 144 filed by Hinge Health Inc.

Hinge Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

Hinge Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

$HNGE
Press Releases

Hinge Health to announce second quarter 2026 financial results on August 4, 2026

Hinge Health adds surgery to HingeSelect, delivering a fully integrated musculoskeletal care platform

Hinge Health hosts its first Investor Day and raises guidance

$HNGE
Analyst Ratings

Wells Fargo initiated coverage on Hinge Health with a new price target

Robert W. Baird initiated coverage on Hinge Health with a new price target

Citizens JMP initiated coverage on Hinge Health with a new price target

$HNGE
Leadership Updates

Hinge Health appoints Tyler Sloat to its board of directors

$HNGE
Financials

Hinge Health to announce second quarter 2026 financial results on August 4, 2026

Hinge Health reports record first quarter 2026 financial results

Hinge Health to announce first quarter 2026 financial results on May 5, 2026

Large owner Insight Holdings Group, Llc converted options into 530,982 shares and sold $38,137,011 worth of shares (530,982 units at $71.82) (SEC Form 4)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $HNGE

Large owner Insight Holdings Group, Llc converted options into 530,982 shares and sold $38,137,011 worth of shares (530,982 units at $71.82) (SEC Form 4)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $HNGE

$HNGE Insider Trading

Large owner Insight Holdings Group, Llc converted options into 426,171 shares and sold $38,446,957 worth of shares (426,171 units at $90.21) (SEC Form 4)

Director Sloat Tyler was granted 246 shares, increasing direct ownership by 2% to 10,210 units (SEC Form 4)

Chief Financial Officer Budge James covered exercise/tax liability with 4,614 shares, decreasing direct ownership by 1% to 430,786 units (SEC Form 4) to satisfy tax liability

$HNGE SEC Filings

SEC Form 144 filed by Hinge Health Inc.

Hinge Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

Hinge Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

$HNGE Press Releases

Hinge Health to announce second quarter 2026 financial results on August 4, 2026

Hinge Health adds surgery to HingeSelect, delivering a fully integrated musculoskeletal care platform

Hinge Health hosts its first Investor Day and raises guidance

$HNGE Analyst Ratings

Wells Fargo initiated coverage on Hinge Health with a new price target

Robert W. Baird initiated coverage on Hinge Health with a new price target

Citizens JMP initiated coverage on Hinge Health with a new price target

$HNGE Leadership Updates

Hinge Health appoints Tyler Sloat to its board of directors

$HNGE Financials

Hinge Health to announce second quarter 2026 financial results on August 4, 2026

Hinge Health reports record first quarter 2026 financial results

Hinge Health to announce first quarter 2026 financial results on May 5, 2026

Recent Analyst Ratings for
$HNGE

Recent Analyst Ratings for
$HNGE

$HNGE
Insider Trading

$HNGE
SEC Filings

$HNGE
Press Releases

$HNGE
Analyst Ratings

$HNGE
Leadership Updates

$HNGE
Financials